{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:17:44Z","timestamp":1759483064317},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"GL PharmTech Corporation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clinthera.2018.10.017","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T09:39:59Z","timestamp":1543311599000},"page":"2112-2124","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers"],"prefix":"10.1016","volume":"40","author":[{"given":"Tae-Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Young","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chang Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Gul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.10.017_bib1","unstructured":"Lyrica [package insert ]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/021446s032,022488s011lbl.pdf. Last accessed 19 November 2018."},{"key":"10.1016\/j.clinthera.2018.10.017_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12871-015-0150-5","article-title":"Clinical practice guidelines for the management of neuropathic pain: a systematic review","volume":"16","author":"Deng","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.clinthera.2018.10.017_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/03639045.2010.535211","article-title":"A\u00a0novel three-layered tablet for extended release with various layer formulations and in\u00a0vitro release profiles","volume":"37","author":"Park","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.clinthera.2018.10.017_bib4","series-title":"Food-effect BIoavailability and Fed Bioequivalence Studies","author":"US Food and Drug Administration Guidance","year":"2002"},{"key":"10.1016\/j.clinthera.2018.10.017_bib5","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A\u00a0new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2018.10.017_bib6","first-page":"281","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.clinthera.2018.10.017_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2018.10.017_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanpaa","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2018.10.017_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pain.2008.04.025","article-title":"The kyoto protocol of IASP basic pain terminology","volume":"137","author":"Loeser","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2018.10.017_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2018.10.017_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain\u2014is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2018.10.017_bib12","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clinthera.2018.10.017_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.clinthera.2018.10.017_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0016-5085(86)90573-1","article-title":"Human interdigestive motility: variations in patterns from esophagus to colon","volume":"91","author":"Kellow","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2018.10.017_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0016-5085(86)90696-7","article-title":"Circadian variation in the propagation velocity of the migrating motor complex","volume":"91","author":"Kumar","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2018.10.017_bib16","first-page":"1489","article-title":"Prolonged ambulatory antroduodenal manometry in humans","volume":"89","author":"Wilson","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2018.10.017_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/papr.12146","article-title":"A\u00a0comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain","volume":"15","author":"Freynhagen","year":"2015","journal-title":"Pain Pract"},{"key":"10.1016\/j.clinthera.2018.10.017_bib18","unstructured":"Lyrica CR [package insert]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209501s000lbl.pdf. Last accessed 19 November 2018."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818305125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818305125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T15:20:15Z","timestamp":1548775215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818305125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0149291818305125"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.10.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}